Profile data is unavailable for this security.
About the company
Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation services. The Company mainly conducts its businesses in the domestic market.
- Revenue in HKD (TTM)0.00
- Net income in HKD-340.29m
- Incorporated2018
- Employees211.00
- LocationImmunotech Biopharm Ltd8th Floor, Building 1Guosheng Science and Technology ParkNo.1 Kangding Street, Economic and TechnBeijing ChinaCHN
- Websitehttp://www.eaal.net/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genor Biopharma Holdings Ltd | 15.92m | -578.31m | 857.97m | 28.00 | -- | 0.7257 | -- | 53.88 | -1.14 | -1.14 | 0.0313 | 2.27 | 0.0093 | 0.0178 | 0.2277 | 153,116.50 | -33.87 | -55.46 | -39.06 | -63.73 | 97.59 | 66.56 | -3,638.27 | -14,819.18 | 5.73 | -- | 0.003 | -- | -100.00 | -- | 7.65 | -- | -48.85 | -- |
| Sunho Biologics Inc | -100.00bn | -118.07m | 924.33m | -- | -- | 1.53 | -- | -- | -0.8765 | -0.8765 | -- | 3.85 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.77 | -4,626.67 | 0.0516 | -- | -- | -- | -155.25 | -- | -- | -- |
| Wuhan YZY Biopharma Co Ltd | 0.00 | -201.97m | 1.20bn | 114.00 | -- | 21.92 | -- | -- | -1.06 | -1.06 | 0.00 | 0.2815 | 0.00 | -- | -- | 0.00 | -83.99 | -- | -230.17 | -- | -- | -- | -- | -- | 1.21 | -44.35 | 0.7078 | -- | -- | -- | -1.50 | -- | -- | -- |
| Frontage Holdings Corp | 2.03bn | 47.53m | 1.24bn | 1.66k | 26.53 | 0.4735 | 3.67 | 0.613 | 0.023 | 0.023 | 0.9892 | 1.29 | 0.4701 | 56.23 | 4.18 | 1,151,748.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.19 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Hua Medicine | 119.89m | -289.85m | 1.26bn | 172.00 | -- | -- | -- | 10.48 | -0.2957 | -0.2957 | 0.1223 | -0.0372 | 0.0779 | 1.51 | 1.90 | 677,343.20 | -18.84 | -25.61 | -23.63 | -28.81 | 37.72 | -- | -241.76 | -1,654.70 | 4.64 | -- | 1.14 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
| Mabpharm Ltd | 166.86m | -227.72m | 1.26bn | 347.00 | -- | 9.92 | -- | 7.54 | -0.0552 | -0.0552 | 0.0405 | 0.0307 | 0.164 | 0.1937 | 3.26 | 480,867.20 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -23.09 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 25.51m | -398.26m | 1.38bn | 298.00 | -- | 1.39 | -- | 54.14 | -0.513 | -0.513 | 0.0329 | 1.26 | 0.016 | -- | 2.41 | 84,767.09 | -24.89 | -45.76 | -28.66 | -49.30 | 3.45 | -- | -1,560.88 | -372.22 | -- | -- | 0.1794 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| Immunotech Biopharm Ltd | 0.00 | -340.29m | 1.38bn | 211.00 | -- | 15.51 | -- | -- | -0.6613 | -0.6613 | 0.00 | 0.1734 | 0.00 | -- | -- | 0.00 | -35.21 | -37.42 | -55.75 | -45.48 | -- | -- | -- | -- | 0.3638 | -2.44 | 0.6119 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
| TOT Biopharm International Co Ltd | 1.07bn | 9.87m | 1.55bn | 551.00 | 147.04 | 1.94 | 22.12 | 1.44 | 0.0136 | 0.0136 | 1.48 | 1.03 | 0.6899 | 2.44 | 6.35 | 1,943,674.00 | 0.6356 | -20.01 | 0.8392 | -25.21 | 72.02 | 74.74 | 0.9212 | -68.53 | 1.63 | 2.98 | 0.3465 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Laekna Inc | 0.00 | -325.23m | 1.75bn | 92.00 | -- | 2.35 | -- | -- | -0.9127 | -0.9127 | 0.00 | 1.91 | 0.00 | -- | -- | 0.00 | -31.46 | -- | -35.71 | -- | -- | -- | -- | -- | -- | -- | 0.0856 | -- | -- | -- | 52.81 | -- | -- | -- |
| CARsgen Therapeutics Holdings Ltd | 6.98m | -764.71m | 1.76bn | 477.00 | -- | 1.08 | -- | 252.30 | -1.37 | -1.37 | 0.0125 | 2.86 | 0.0027 | -- | 0.302 | 13,521.54 | -29.27 | -- | -32.86 | -- | 25.50 | -- | -10,960.25 | -- | 9.44 | -- | 0.1246 | -- | -- | -- | 16.19 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 1.99bn | 145.00 | -- | 3.01 | -- | -- | -- | -- | -- | 1.77 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| CStone Pharmaceuticals | 502.41m | -156.61m | 1.99bn | 164.00 | -- | 3.87 | -- | 3.96 | -0.1229 | -0.1229 | 0.3941 | 0.4008 | 0.2861 | 1.33 | 2.50 | 2,184,394.00 | -8.92 | -54.76 | -16.99 | -81.68 | 70.73 | -- | -31.17 | -301.62 | 1.45 | -- | 0.4171 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
Data as of Sep 20 2024. Currency figures normalised to Immunotech Biopharm Ltd's reporting currency: Hong Kong Dollar HKD
0.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 622.00k | 0.12% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
Data from 30 Jun 2024 - 12 Sep 2024Source: FactSet Research Systems Inc.
